Home›Companies›Healthcare›Amplitude Vascular Systems

Amplitude Vascular Systems, Inc.

Updated Oct 27, 2026·Latest SEC filing Oct 18, 2024·Suggest an edit

About Amplitude Vascular Systems

Amplitude Vascular Systems is a private company based in Boston, Massachusetts, incorporated in 2019 in Delaware. It has reported $29,292,551 raised in three offerings on Form D since July 2020.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 15, 2024Oct 18, 2024$23,647,307of $36.0M target4$5.9MEquityRule 506(b)Form D ↗
Oct 17, 2022Oct 26, 2022$4,405,244of $22.4M target3$1.4MEquityRule 506(b)Form D ↗
Jun 25, 2020Jul 7, 2020$1,240,000of $1.5M target4$310KEquityRule 506(b)Form D ↗
Total, three offerings$29,292,551

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Amplitude Vascular Systems's Form D filed Oct 18, 2024.

HG
RC
Robert Chisena
Executive officer
LC
Louis Cannon
Director
AC
Andrew Casey
Executive officer
SG
Sean Gilligan
Executive officer
MT
Mark Toland
Executive officer and director

Earlier filings also listed Hank Kucheman (director, last listed Oct 2022) and David Long (director, last listed Oct 2022).

Sources

  1. SECAmplitude Vascular Systems, Inc. filing history